the full WP markdown article
Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost
Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to Zepbound and Mounjaro. But what does the strong 2026 guidance really mean for investors, and is the GLP-1 boom here to stay? ...
Financial market analysis from 04/02/2026. Market conditions may have changed since publication.
❝
The best time to plant a tree was 20 years ago. The second-best time is now.
— Chinese Proverb
Author
Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.
Previous
AMD Stock Drops 9% Post-Earnings: What Really Happened
Next
Sheryl Sandberg Backs AI Workplace Startup Slashwork
Related Articles
Altcoins
Trump at Davos 2026: Reshaping Global Power Dynamics
As President Trump arrives at Davos amid sweeping changes at the World Economic Forum, his presence signals a dramatic challenge to the old global order. With bold moves on Greenland and recent international actions stirring debate, what unexpected shifts could unfold next?
Jan 20, 2026
7 min read
Market News
Campbell’s VP Calls Soup “Food for Poor People” in Shocking Leak
A senior Campbell's executive was secretly recorded saying their famous soup is basically "shit for poor people" and complaining about ingredients that sound straight out of a sci-fi lab. He doesn't even feed it to his own family. Once you hear what he said next...
Nov 25, 2025
5 min read
Growth Picks
Why Amazon’s Stock Is a Top Pick for 2025 Growth
Amazon's stock is surging with AI and retail strength. Could this be the best investment for 2025? Click to find out why analysts are bullish!
Jul 23, 2025
6 min read